Drug Enforcement Agency

India: visa problems for English cricketer reflect a longstanding security rift with neighbouring Pakistan

Retrieved on:

Tuesday, January 30, 2024

This is not the first time a visiting cricketer has had visa problems in India.

Key Points:

This is not the first time a visiting cricketer has had visa problems in India.
Headley, in his visa application, had concealed his Pakistani roots and managed to visit India multiple times to reconnoitre the targets.
As a result, the Indian Home Ministry (MHA), which is in charge of internal security, decided to tighten the visa requirements.
The US and UK governments lodged diplomatic protests against India’s decision to tighten its visa rules, but the Indian government resisted the pressure.
Mindful of international pressure to exercise restraint in the aftermath of the attacks, the then Manmohan Singh government instituted several defensive counter-terrorism measures, including the new visa rules.

Modi’s neighbourhood policy

This aimed to encourage cross-border cooperation and business enterprise across South Asia and focused on building deeper people-to-people ties.
But as terrorist attacks from Pakistan continued, India changed its tack to more forceful measures targeting terrorist bases within Pakistan.
As a result, a new mantra became popular in Indian government circles: “terror and talks cannot go together”.

Focus on counter-terrorism

Meanwhile a focus on regional counter-terrorism has become something of a mantra for Modi’s ruling Bharatiya Janata Party (BJP).
Seen within this paradigm, India’s approach towards Pakistan is unlikely to change as the country expects its general elections in April.
A hostile military in control of domestic politics combined with strong anti-India public opinion invalidate any prospects for reestablishing ties with India.

Dheeraj Paramesha does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

American Council of Cannabis Medicine Prepares DEA Rescheduling Application; Backs HHS Directive on Cannabis Rescheduling Industry Input Opens This Week

Retrieved on:

Thursday, September 21, 2023

Dr. Annabelle Manalo-Morgan, author, research scientist, and Chair of ACCM's Research Committee, expressed enthusiasm about the potential this shift holds for medical cannabis.

Key Points:

Dr. Annabelle Manalo-Morgan, author, research scientist, and Chair of ACCM's Research Committee, expressed enthusiasm about the potential this shift holds for medical cannabis.
Recognizing our responsibility as the leading voice for medical cannabis, we initiated the DEA cannabis rescheduling application process and anticipate its finalization by October."
The ACCM is currently taking input on its DEA application from members of Congress and invites industry stakeholders to share their insights until October 30th, 2023,via www.accmforum.org/deavoice
The American Council of Cannabis Medicine is the "Voice of American Medical Cannabis."
Reach the American Council of Cannabis Medicine at 202-349-9650, or www.accmforum.org
Explore ACCM's Next Frontier Task Force at: www.nextfrontier.us

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Hims & Hers Health, Inc. (NYSE: HIMS)

Retrieved on:

Thursday, July 13, 2023

Download or view the report by visiting www.SprucePointCap.com and follow us on Twitter @SprucePointCap for additional information and exclusive updates.

Key Points:

Download or view the report by visiting www.SprucePointCap.com and follow us on Twitter @SprucePointCap for additional information and exclusive updates.
Hims & Hers is a health and wellness e-commerce company that came public in January 2021 through a SPAC merger.
In fact, we believe they are “figureheads” who can be replaced at the whim of Hims & Hers management.
As a reminder, our full report, along with its investment disclaimers, can be downloaded and viewed at www.SprucePointCap.com .

Northeast Delta HSA to host Opioid Summit on June 15, "Building Resilience for Recovery through Trauma-Informed Care"

Retrieved on:

Tuesday, June 6, 2023

LCSW, University, Army, Opioid, Law enforcement, Hazelden Betty Ford Foundation, Drug Enforcement Agency, DSM-IV codes, Clergy, Social work, Death, Embedded Training Teams, DEA, Indiana University School of Medicine, Trauma, Consultant, Rare-earth element, Nursing

MONROE, La., June 6, 2023 /PRNewswire-PRWeb/ -- Northeast Delta Human Services Authority (NEDHSA) is set to host its 2023 Opioid Summit on Thursday, June 15, from 9 a.m. to 4 p.m. at the Bayou Pointe Event Center at the University of Louisiana Monroe. The theme for the 2023 Opioid Summit is "Building Resilience for Recovery through Trauma-Informed Care."

Key Points:

The theme for the 2023 Opioid Summit is "Building Resilience for Recovery through Trauma-Informed Care."
MONROE, La., June 6, 2023 /PRNewswire-PRWeb/ -- Northeast Delta Human Services Authority (NEDHSA) is set to host its 2023 Opioid Summit on Thursday, June 15, from 9 a.m. to 4 p.m. at the Bayou Pointe Event Center at the University of Louisiana Monroe.
The theme for the 2023 Opioid Summit is "Building Resilience for Recovery through Trauma-Informed Care."
"Our current opioid crisis will be mitigated when we learn how to effectively work across race, class, governmental silos, and political divisions.

Aseptic Health Introduces SoRite DECON: The Revolutionary Decontaminant That Eradicates Fentanyl in 60 Seconds

Retrieved on:

Wednesday, May 24, 2023

NASHVILLE, Tenn., May 24, 2023 /PRNewswire-PRWeb/ -- Aseptic Health LLC, a renowned provider of innovative products for public safety, announces SoRite DECON, a new decontaminant that destroys narcotics like fentanyl, xylazine, and heroin in just 60 seconds. Unlike other decontaminants, SoRite DECON has been tested and verified to eradicate, not just neutralize, fentanyl at a third-party, Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) registered laboratory.

Key Points:

Aseptic Health has released SoRite DECON, a new decontaminant that destroys narcotics like fentanyl, xylazine, and heroin in just 60 seconds.
NASHVILLE, Tenn., May 24, 2023 /PRNewswire-PRWeb/ -- Aseptic Health LLC, a renowned provider of innovative products for public safety, announces SoRite DECON, a new decontaminant that destroys narcotics like fentanyl, xylazine, and heroin in just 60 seconds.
In response to this national epidemic, Aseptic Health LLC created SoRite DECON, a patent-pending decontaminant that destroys organic compounds and specifically narcotics like fentanyl, xylazine (also known as "tranq" or "zombie drug") and heroin in just 60 seconds.
SoRite DECON has been tested and verified to eradicate, not neutralize, fentanyl at a third-party, Drug Enforcement Agency (DEA) approved laboratory.

Maridose Announces Federal License from the U.S. Department of Justice and Drug Enforcement Agency for Bulk Manufacture and Sale of Cannabis and Cannabis-Derived Products

Retrieved on:

Friday, August 19, 2022

Federal, Drug Enforcement Agency, THC, Research, University, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, DEA, Cannabis, Drug, Science, Justice, Schedule 1

The license granted to Maridose is a step toward ending that monopoly and expanding access to modern cannabis strains for research on cannabis and cannabis-derived products.

Key Points:

The license granted to Maridose is a step toward ending that monopoly and expanding access to modern cannabis strains for research on cannabis and cannabis-derived products.
Maridose is now an alternative to the University of Mississippi and is licensed by the Drug Enforcement Agency to supply cannabis and its extracts for research use in the United States.
The company was selected by the U.S. Department of Justice and Drug Enforcement Agency to legally cultivate, manufacture and sell cannabis and cannabis-derived products under federal law for research and pharmaceutical applications.
Maridose is establishing a center of excellence in Brunswick Landing, Maine for best in class cannabis cultivation, research and product development.

Global Industrial Hemp Market Report (2022 to 2027) - Featuring Aurora Cannabis, Ecofibre and Hemp Among Others - ResearchAndMarkets.com

Retrieved on:

Wednesday, June 22, 2022

The growing acceptance of industrial hemp in numerous industries, coupled with the loosening of strict rules, has increased the market value.

Key Points:

The growing acceptance of industrial hemp in numerous industries, coupled with the loosening of strict rules, has increased the market value.
However, in numerous countries, industrial hemp is highly regulated owing to the presence of THC, which constrains the market.
The North American market for Industrial Hemp is anticipated to hold a dominating share owing to greater acceptance of THC.
Based on type, the Industrial Hemp market has been segmented into hemp seed and oil, hemp fibre, and CBD hemp oil.

United States Intoxicating Hemp Products Market Report 2021: Opportunity or Risk? - ResearchAndMarkets.com

Retrieved on:

Wednesday, January 19, 2022

Tobacco, Retail, Risk, US Foods, Drug, THCP, Drug Enforcement Agency, United States farm bill, Food, THC, FDA, HHC, 2018 United States farm bill, 2020 Indian agriculture acts, DEA

The "Intoxicating Hemp Products in the US - Opportunity or Risk?"

Key Points:

The "Intoxicating Hemp Products in the US - Opportunity or Risk?"
Despite the intent of the 2018 US Farm Bill to restrict intoxicating substances made from hemp, some companies are selling intoxicating cannabinoid products and claiming legality under the Farm Bill.
However THCP, an intoxicating cannabinoid discovered in 2019, is too novel to fully establish its legal status.
The US Food and Drug Administration (FDA) and potentially the Drug Enforcement Agency (DEA), could bring enforcement action against producers of some of these intoxicating products if they so choose.